Name | BMS813160 |
---|---|
Synonyms | BMS-813160 |
Description | BMS-813160 is the first dual CCR2/CCR5 antagonist to enter clinical development for cardiovascular. |
---|---|
Related Catalog | |
Target |
CCR2 CCR5 |
References |
Molecular Formula | C25H40N8O2 |
---|---|
Molecular Weight | 484.64 |
Storage condition | 2-8℃ |